Zymeworks (ZYME) EBITDA Margin (QoQ) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21,447.00 |
| Dec 31, 2025 | -156,243.00 |
| Sep 30, 2025 | -8,214.00 |
| Jun 30, 2025 | 71,747.00 |
| Mar 31, 2025 | -63,376.00 |
| Dec 31, 2024 | 9,584.00 |
| Sep 30, 2024 | 29,867.00 |
| Jun 30, 2024 | -14,657.00 |
| Mar 31, 2024 | -25,121.00 |
| Dec 31, 2023 | 10,119.00 |
| Sep 30, 2023 | 58,056.00 |
| Jun 30, 2023 | -69,087.00 |
| Mar 31, 2023 | -16,164.00 |
| Dec 31, 2022 | 191,376.00 |
| Sep 30, 2022 | -63,114.00 |
| Jun 30, 2022 | 260,304.00 |
| Mar 31, 2022 | -330,105.00 |
| Dec 31, 2021 | 88,896.00 |